PASSAT(EPA:PSAT) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to PSAT. PSAT was compared to 15 industry peers in the Broadline Retail industry. PSAT has an excellent financial health rating, but there are some minor concerns on its profitability. PSAT has a valuation in line with the averages, but on the other hand it scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

PSAT had positive earnings in the past year.

In the past year PSAT had a positive cash flow from operations.

Each year in the past 5 years PSAT has been profitable.

Of the past 5 years PSAT 4 years had a positive operating cash flow.

1.2 Ratios

PSAT has a worse Return On Assets (1.98%) than 71.43% of its industry peers.

PSAT has a worse Return On Equity (3.29%) than 64.29% of its industry peers.

PSAT has a Return On Invested Capital (5.31%) which is in line with its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for PSAT is in line with the industry average of 9.93%.

		Industry Rank	Sector Rank
ROA	1.98%
ROE	3.29%
ROIC	5.31%

ROA(3y)3.75%

ROA(5y)4.19%

ROE(3y)5.67%

ROE(5y)5.9%

ROIC(3y)7.99%

ROIC(5y)8.11%

1.3 Margins

PSAT's Profit Margin of 2.09% is on the low side compared to the rest of the industry. PSAT is outperformed by 71.43% of its industry peers.

PSAT's Profit Margin has improved in the last couple of years.

Looking at the Operating Margin, with a value of 5.08%, PSAT is doing worse than 64.29% of the companies in the same industry.

In the last couple of years the Operating Margin of PSAT has grown nicely.

PSAT has a better Gross Margin (57.70%) than 78.57% of its industry peers.

PSAT's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	5.08%
PM (TTM)	2.09%
GM	57.7%

OM growth 3Y-6.22%

OM growth 5Y29.84%

PM growth 3Y-17.46%

PM growth 5Y14.99%

GM growth 3Y-0.15%

GM growth 5Y0.5%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PSAT is creating some value.

The number of shares outstanding for PSAT remains at a similar level compared to 1 year ago.

Compared to 5 years ago, PSAT has about the same amount of shares outstanding.

Compared to 1 year ago, PSAT has a worse debt to assets ratio.

2.2 Solvency

PSAT has an Altman-Z score of 3.10. This indicates that PSAT is financially healthy and has little risk of bankruptcy at the moment.

PSAT's Altman-Z score of 3.10 is in line compared to the rest of the industry. PSAT outperforms 42.86% of its industry peers.

PSAT has a debt to FCF ratio of 5.51. This is a neutral value as PSAT would need 5.51 years to pay back of all of its debts.

PSAT has a Debt to FCF ratio (5.51) which is in line with its industry peers.

PSAT has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of PSAT (0.23) is better than 92.86% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.23
Debt/FCF	5.51
Altman-Z	3.1

ROIC/WACC0.7

WACC7.63%

2.3 Liquidity

PSAT has a Current Ratio of 3.51. This indicates that PSAT is financially healthy and has no problem in meeting its short term obligations.

PSAT has a better Current ratio (3.51) than 85.71% of its industry peers.

A Quick Ratio of 2.45 indicates that PSAT has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 2.45, PSAT belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.51
Quick Ratio	2.45

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for PSAT have decreased strongly by -67.23% in the last year.

PSAT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.40% yearly.

Looking at the last year, PSAT shows a quite strong growth in Revenue. The Revenue has grown by 16.52% in the last year.

PSAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.43% yearly.

EPS 1Y (TTM)-67.23%

EPS 3Y-0.35%

EPS 5Y30.4%

EPS Q2Q%-125.86%

Revenue 1Y (TTM)16.52%

Revenue growth 3Y20.73%

Revenue growth 5Y13.43%

Sales Q2Q%-3.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.42, the valuation of PSAT can be described as correct.

PSAT's Price/Earnings ratio is rather cheap when compared to the industry. PSAT is cheaper than 85.71% of the companies in the same industry.

PSAT is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	14.42
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PSAT indicates a rather cheap valuation: PSAT is cheaper than 100.00% of the companies listed in the same industry.

78.57% of the companies in the same industry are more expensive than PSAT, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	11.49
EV/EBITDA	1.04

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)0.47

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for PSAT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PASSAT

EPA:PSAT (3/7/2025, 7:00:00 PM)

4.76

-0.02 (-0.42%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustryBroadline Retail

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners5.79%

Ins Owner ChangeN/A

Market Cap19.99M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.7

Dividend Growth(5Y)-2.64%

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	14.42
Fwd PE	N/A
P/S	0.32
P/FCF	11.49
P/OCF	5.22
P/B	0.5
P/tB	0.56
EV/EBITDA	1.04

EPS(TTM)0.33

EY6.93%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.41

FCFY8.7%

OCF(TTM)0.91

OCFY19.15%

SpS14.99

BVpS9.52

TBVpS8.52

PEG (NY)N/A

PEG (5Y)0.47

Profitability

		Industry Rank	Sector Rank
ROA	1.98%
ROE	3.29%
ROCE	6.42%
ROIC	5.31%
ROICexc	10.18%
ROICexgc	12.13%
OM	5.08%
PM (TTM)	2.09%
GM	57.7%
FCFM	2.76%

ROA(3y)3.75%

ROA(5y)4.19%

ROE(3y)5.67%

ROE(5y)5.9%

ROIC(3y)7.99%

ROIC(5y)8.11%

ROICexc(3y)14.61%

ROICexc(5y)16.94%

ROICexgc(3y)15.97%

ROICexgc(5y)19.27%

ROCE(3y)9.66%

ROCE(5y)9.81%

ROICexcg growth 3Y-6%

ROICexcg growth 5Y31.7%

ROICexc growth 3Y-4.22%

ROICexc growth 5Y31.57%

OM growth 3Y-6.22%

OM growth 5Y29.84%

PM growth 3Y-17.46%

PM growth 5Y14.99%

GM growth 3Y-0.15%

GM growth 5Y0.5%

F-Score5

Asset Turnover0.95

Health

		Industry Rank	Sector Rank
Debt/Equity	0.23
Debt/FCF	5.51
Debt/EBITDA	1.64
Cap/Depr	90.08%
Cap/Sales	3.32%
Interest Coverage	250
Cash Conversion	69.4%
Profit Quality	132.22%
Current Ratio	3.51
Quick Ratio	2.45
Altman-Z	3.1

F-Score5

WACC7.63%

ROIC/WACC0.7

Cap/Depr(3y)81.8%

Cap/Depr(5y)87.35%

Cap/Sales(3y)2.54%

Cap/Sales(5y)2.57%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-67.23%

EPS 3Y-0.35%

EPS 5Y30.4%

EPS Q2Q%-125.86%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)16.52%

Revenue growth 3Y20.73%

Revenue growth 5Y13.43%

Sales Q2Q%-3.23%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-57.99%

EBIT growth 3Y13.23%

EBIT growth 5Y47.28%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y145.41%

FCF growth 3Y57.72%

FCF growth 5Y13.84%

OCF growth 1Y242.04%

OCF growth 3Y41.84%

OCF growth 5Y14.68%

PASSAT (PSAT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens